The Hague, Dec 20 (AP) The European Union's drugs regulator gave the green light Monday to a fifth COVID-19 vaccine for use in the 27-nation bloc, granting conditional marketing authorization to the two-dose vaccine made by US biotech company Novavax.

The European Medicines Agency decision to grant conditional marketing authorisation for the vaccine for people aged 18 and over, which must be confirmed by the EU's executive commission, comes as many European nations are battling surges in infections and amid concerns about the spread of the new omicron variant.

Also Read | Maryam Nawaz Can Be A Model, Camera Loves Her, Says Junaid Safdar's Wedding Photographer Irfan Ahson.

Novavax says it currently is testing how its shots will hold up against the omicron variant, and like other manufacturers has begun formulating an updated version to better match that variant in case in case it's eventually needed. (AP)

(The above story is verified and authored by Press Trust of India (PTI) staff. PTI, India’s premier news agency, employs more than 400 journalists and 500 stringers to cover almost every district and small town in India.. The views appearing in the above post do not reflect the opinions of LatestLY)